The link between phospho-eIF4E and depression is further strengthened by the fact that chronic fluoxetine treatment (10 mg/kg for 21 d) requires eIF4E phosphorylation to exert its antidepressant effect (Fig. 5). This evidence concerns the gene EIF4E and major depressive disorder.